Live SpaceX Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Beyond Air, Inc.

Get SEC filing alerts via email and in your feed for Beyond Air, Inc.

XAIR

Beyond Air, Inc.

About Beyond Air, Inc.

Beyond Air, Inc. develops and commercializes medical devices and biopharmaceutical products based on nitric oxide (NO) delivery technology. Its LungFit® platform generates NO from ambient air for respiratory treatments, including FDA-approved therapy for persistent pulmonary hypertension of the newborn (PPHN) and investigational uses in lung infections and chronic pulmonary diseases. The company targets hospitals and healthcare providers with innovative, portable NO delivery systems offering antimicrobial and vasodilatory benefits.
This description was generated via AI from an annual report. Updated 9 months ago.

Latest SEC Filings from Beyond Air, Inc.

1
1
Beyond Air, Inc. Beyond Air Reports Revenue Growth to $2.2 Million and Improved Net Loss in Latest 10-Q Filing

Via official filing (AI summary) | 4 months ago | 0 comments

2
1
Beyond Air, Inc. Beyond Air Reports Revenue Growth and Reduced Net Losses in Q2 Fiscal 2025

Via official filing (AI summary) | 7 months ago | 0 comments

3
1
Beyond Air, Inc. Beyond Air Reports Revenue Growth to $1.76 Million and Improved Net Loss in Latest 10-Q Filing

Via official filing (AI summary) | 10 months ago | 0 comments

4
1
Beyond Air, Inc. Beyond Air Reports $48.5 Million Net Loss and $3.7 Million Revenue for Fiscal Year Ended March 31, 2025

Via official filing (AI summary) | 12 months ago | 0 comments

5
1
Beyond Air, Inc. Beyond Air Reports Revenue Growth and CE Mark Approval for LungFit® PH System

Via official filing (AI summary) | over 1 year ago | 0 comments

6
1
Beyond Air, Inc. Beyond Air Reports Significant Revenue Growth, Reduced Expenses, and Improved Financial Position in Latest 10-Q Filing

Via official filing (AI summary) | over 1 year ago | 0 comments